Capital Impact Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$2.04M Sell
2021
Q2
$2.38M Buy
2021
Q1
$1.43M Sell
2020
Q4
$2.12M Hold
2020
Q3
$2.13M Hold
2020
Q2
$2.7M Hold
2020
Q1
$1.91M Buy
2019
Q4
$2.27M Buy
2019
Q3
$1.67M Sell
2019
Q2
$1.72M Buy